Cite

HARVARD Citation

    Awada, A. et al. (2022). Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib. Critical reviews in oncology/hematology. p. . [Online]. 
  
Back to record